Plantain Extract to Target Crohn’s Disease
UK-based ingredient supplier Provexis says it is developing a plantain-derived extract that may provide support for Crohn’s disease patients during remission.
UK-based ingredient supplier Provexis says it is developing a plantain-derived extract that may provide support for Crohn’s disease patients during remission.
“The new ingredient, which comes from a fiber found in plantain, works by inhibiting the interaction between Escherichia coli bacteria often found in Crohn’s disease patients and cells lining the intestine,” the company says. “As E. coli bacteria have been found to interrupt a number of immunological interactions, their inhibition could potentially have a range of therapeutic benefits for the patient.”
The company says it is currently conducting a randomized controlled study to examine the effects of the extract in maintaining remission in Crohn’s disease patients at four centers in the UK. It says that preliminary trials in healthy humans showed no significant adverse effects on markers of gastrointestinal health over a 21-day supplementation period.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
